XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Expenses:    
Research and development $ 81,076 $ 240,370
Selling, general and administrative 149,623 212,870
Total expenses (230,699) (453,240)
Loss from operations (230,699) (453,240)
Net loss $ (230,699) $ (453,240)
Net loss per share - basic and diluted (in dollars per share) $ (0.01) $ (0.01)
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568